These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15276657)

  • 1. One-year course of the first vs. multiple episodes of depression--Polish naturalistic study.
    Rybakowski JK; Nawacka D; Kiejna A
    Eur Psychiatry; 2004 Aug; 19(5):258-63. PubMed ID: 15276657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical picture and treatment of subsequent depressive episodes--results of Polish multicenter study].
    Rybakowski J; Kiejna A; Nawacka-Pawlaczyk D; Kargul M
    Psychiatr Pol; 2003; 37(3):419-31. PubMed ID: 13677972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study.
    Ciudad A; Álvarez E; Roca M; Baca E; Caballero L; García de Polavieja P; Casillas M; Valladares A; Gilaberte I
    J Clin Psychiatry; 2012 Feb; 73(2):185-91. PubMed ID: 22053897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review.
    de Zwart PL; Jeronimus BF; de Jonge P
    Epidemiol Psychiatr Sci; 2019 Oct; 28(5):544-562. PubMed ID: 29769159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical differences between early and late remission in depressive patients.
    Roca M; García-Toro M; García-Campayo J; Vives M; Armengol S; García-García M; Asensio D; Gili M
    J Affect Disord; 2011 Nov; 134(1-3):235-41. PubMed ID: 21676465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of depressive episodes, their recurrence and pharmacologic treatment in primary care patients: A retrospective descriptive study.
    Nuggerud-Galeas S; Sáez-Benito Suescun L; Berenguer Torrijo N; Sáez-Benito Suescun A; Aguilar-Latorre A; Magallón Botaya R; Oliván Blázquez B
    PLoS One; 2020; 15(5):e0233454. PubMed ID: 32437398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2004 Jun; 65(6):810-9. PubMed ID: 15291658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study.
    Klein DN; Schwartz JE; Rose S; Leader JB
    Am J Psychiatry; 2000 Jun; 157(6):931-9. PubMed ID: 10831473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting relapse in major depression after successful initial pharmacological treatment.
    Akechi T; Mantani A; Kurata K; Hirota S; Shimodera S; Yamada M; Inagaki M; Watanabe N; Kato T; Furukawa TA;
    J Affect Disord; 2019 May; 250():108-113. PubMed ID: 30851699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study.
    Maj M; Veltro F; Pirozzi R; Lobrace S; Magliano L
    Am J Psychiatry; 1992 Jun; 149(6):795-800. PubMed ID: 1590496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates and predictors of remission, recurrence and conversion to bipolar disorder after the first lifetime episode of depression--a prospective 5-year follow-up study.
    Bukh JD; Andersen PK; Kessing LV
    Psychol Med; 2016 Apr; 46(6):1151-61. PubMed ID: 26743873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidant/antioxidant imbalance is an inherent feature of depression.
    Talarowska M; Szemraj J; Berk M; Maes M; Gałecki P
    BMC Psychiatry; 2015 Apr; 15():71. PubMed ID: 25880127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the dynamics of depression symptoms on outcomes after coronary artery bypass grafting.
    Foss-Nieradko B; Stepnowska M; Piotrowicz R
    Kardiol Pol; 2012; 70(6):591-7. PubMed ID: 22718378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis.
    Nanni V; Uher R; Danese A
    Am J Psychiatry; 2012 Feb; 169(2):141-51. PubMed ID: 22420036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
    McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
    Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD.
    Kornstein SG; Gommoll C; Chen C; Kramer K
    J Affect Disord; 2016 Mar; 193():137-43. PubMed ID: 26773906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.